HEADER TRANSFERASE 03-JUN-19 6P68 TITLE CRYSTAL STRUCTURE OF FGFR1-Y563C (FGFR4 SURROGATE) COVALENTLY BOUND TO TITLE 2 COMPOUND 22. COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: FGFR-1,BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1,BFGF-R-1, COMPND 5 FMS-LIKE TYROSINE KINASE 2,FLT-2,N-SAM,PROTO-ONCOGENE C-FGR; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE-TRANSFER COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.A.LARSEN REVDAT 2 11-OCT-23 6P68 1 REMARK REVDAT 1 19-JUN-19 6P68 0 JRNL AUTH N.A.LARSEN JRNL TITL TO BE PUBLISHED JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 27367 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.303 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1445 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.97 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1299 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 60.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.3330 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.4240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6788 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 121 REMARK 3 SOLVENT ATOMS : 4 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 108.8 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : 0.23000 REMARK 3 B33 (A**2) : -0.20000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.13000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.457 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.341 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.778 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.884 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7047 ; 0.011 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 6788 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9528 ; 1.516 ; 2.002 REMARK 3 BOND ANGLES OTHERS (DEGREES): 15654 ; 0.884 ; 3.004 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 850 ; 6.836 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 302 ;38.685 ;24.338 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1267 ;17.983 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 45 ;16.279 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1041 ; 0.074 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7781 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1481 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6P68 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1000241961. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28812 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.29000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3RHX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1:1 MIX OF PROTEIN + RESERVOIR PROTEIN REMARK 280 AT ~15 MG/ML FORMULATED IN: 20MM TRIS PH 8, 20MM NACL, 2MM TCEP REMARK 280 RESERVOIR: 14-18% PEG 10K 0.3 M (NH4)2SO4 0.1 M MES PH 6.5 5% REMARK 280 ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 96.25000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.63650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 96.25000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 39.63650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 ILE A 648 REMARK 465 HIS A 649 REMARK 465 HIS A 650 REMARK 465 GLN A 764 REMARK 465 GLU A 765 REMARK 465 GLY B 457 REMARK 465 ALA B 458 REMARK 465 GLY B 459 REMARK 465 VAL B 460 REMARK 465 SER B 461 REMARK 465 PRO B 579 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 465 GLY C 457 REMARK 465 ALA C 458 REMARK 465 GLY C 459 REMARK 465 VAL C 460 REMARK 465 SER C 461 REMARK 465 GLU C 462 REMARK 465 GLY C 580 REMARK 465 LEU C 581 REMARK 465 GLU C 582 REMARK 465 TYR C 583 REMARK 465 SER C 584 REMARK 465 TYR C 585 REMARK 465 ASN C 586 REMARK 465 PRO C 587 REMARK 465 SER C 588 REMARK 465 HIS C 589 REMARK 465 ASN C 590 REMARK 465 PRO C 591 REMARK 465 ILE C 648 REMARK 465 HIS C 649 REMARK 465 HIS C 650 REMARK 465 GLN C 764 REMARK 465 GLU C 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 646 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 ARG A 675 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 724 CG OD1 ND2 REMARK 470 ARG B 646 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 655 CG CD CE NZ REMARK 470 ARG B 675 CG CD NE CZ NH1 NH2 REMARK 470 ASN B 724 CG OD1 ND2 REMARK 470 ARG C 646 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 655 CG CD CE NZ REMARK 470 ARG C 675 CG CD NE CZ NH1 NH2 REMARK 470 ASN C 724 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 463 158.63 175.78 REMARK 500 LEU A 484 80.55 -168.66 REMARK 500 ALA A 488 84.37 -63.30 REMARK 500 PHE A 489 153.95 64.01 REMARK 500 LEU A 500 -25.49 76.38 REMARK 500 ASP A 524 -41.27 -28.34 REMARK 500 ALA A 575 2.75 -62.38 REMARK 500 ARG A 622 -28.65 90.45 REMARK 500 PRO A 663 -17.59 -43.99 REMARK 500 LEU A 696 42.22 31.39 REMARK 500 TYR A 701 63.38 32.13 REMARK 500 PHE B 489 133.26 55.57 REMARK 500 LYS B 566 39.51 -85.49 REMARK 500 GLU B 571 -80.37 -44.05 REMARK 500 TYR B 572 -44.84 -24.80 REMARK 500 ARG B 622 -26.28 84.39 REMARK 500 ALA B 625 129.67 176.71 REMARK 500 TYR B 654 -58.80 -120.22 REMARK 500 THR B 657 -170.10 -69.78 REMARK 500 THR B 658 -70.37 -68.19 REMARK 500 LEU B 696 49.36 32.52 REMARK 500 LEU B 750 -33.08 -38.90 REMARK 500 LEU B 760 42.69 -85.65 REMARK 500 ARG C 470 -61.17 -24.02 REMARK 500 ASP C 476 7.54 -65.72 REMARK 500 ALA C 488 93.20 -59.74 REMARK 500 PHE C 489 129.82 61.44 REMARK 500 LEU C 500 6.13 80.45 REMARK 500 ASP C 501 126.28 -171.62 REMARK 500 ASP C 599 -72.28 -62.82 REMARK 500 LEU C 600 -39.66 -29.35 REMARK 500 LYS C 617 32.78 -95.69 REMARK 500 LYS C 618 -3.75 69.57 REMARK 500 ARG C 622 -19.73 77.53 REMARK 500 ASP C 623 37.87 -147.35 REMARK 500 ALA C 625 154.00 174.56 REMARK 500 PHE C 673 -61.22 -106.80 REMARK 500 TYR C 677 78.31 -115.26 REMARK 500 THR C 695 31.35 -99.41 REMARK 500 LEU C 696 60.85 19.13 REMARK 500 ASN C 724 70.72 52.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue O1Y A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide O1Y B 801 and CYS B REMARK 800 563 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide O1Y C 801 and CYS C REMARK 800 563 DBREF 6P68 A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 6P68 B 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 6P68 C 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 6P68 GLY A 457 UNP P11362 EXPRESSION TAG SEQADV 6P68 ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 6P68 CYS A 563 UNP P11362 TYR 563 ENGINEERED MUTATION SEQADV 6P68 SER A 584 UNP P11362 CYS 584 CONFLICT SEQADV 6P68 GLY B 457 UNP P11362 EXPRESSION TAG SEQADV 6P68 ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 6P68 CYS B 563 UNP P11362 TYR 563 ENGINEERED MUTATION SEQADV 6P68 SER B 584 UNP P11362 CYS 584 CONFLICT SEQADV 6P68 GLY C 457 UNP P11362 EXPRESSION TAG SEQADV 6P68 ALA C 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 6P68 CYS C 563 UNP P11362 TYR 563 ENGINEERED MUTATION SEQADV 6P68 SER C 584 UNP P11362 CYS 584 CONFLICT SEQRES 1 A 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 A 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 A 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 A 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 A 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 A 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 A 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 A 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 A 309 VAL GLU CYS ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 A 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 A 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 A 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 A 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 A 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 A 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 A 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 A 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 A 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 A 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 A 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 A 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 A 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 A 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 B 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 B 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 B 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 B 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 B 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 B 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 B 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 B 309 VAL GLU CYS ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 B 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 B 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 B 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 B 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 B 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 B 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 B 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 B 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 B 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 B 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 B 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 B 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 B 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 B 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 B 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 C 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 C 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 C 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 C 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 C 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 C 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 C 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 C 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 C 309 VAL GLU CYS ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 C 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 C 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 C 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 C 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 C 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 C 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 C 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 C 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 C 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 C 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 C 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 C 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 C 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 C 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 C 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET O1Y A 801 37 HET SO4 A 802 5 HET O1Y B 801 37 HET SO4 B 802 5 HET O1Y C 801 37 HETNAM O1Y N-{3-[(6-{[(2,6-DICHLORO-3,5-DIMETHOXYPHENYL) HETNAM 2 O1Y CARBAMOYL](METHYL)AMINO}PYRIMIDIN-4-YL)AMINO]-1-(2- HETNAM 3 O1Y HYDROXYETHYL)-1H-PYRAZOL-4-YL}PROP-2-ENAMIDE HETNAM SO4 SULFATE ION FORMUL 4 O1Y 3(C22 H24 CL2 N8 O5) FORMUL 5 SO4 2(O4 S 2-) FORMUL 9 HOH *4(H2 O) HELIX 1 AA1 PRO A 474 ASP A 476 5 3 HELIX 2 AA2 THR A 521 GLY A 539 1 19 HELIX 3 AA3 ASN A 568 ALA A 575 1 8 HELIX 4 AA4 SER A 596 LYS A 617 1 22 HELIX 5 AA5 ALA A 625 ARG A 627 5 3 HELIX 6 AA6 LEU A 662 MET A 667 5 6 HELIX 7 AA7 ALA A 668 PHE A 673 1 6 HELIX 8 AA8 THR A 678 PHE A 694 1 17 HELIX 9 AA9 PRO A 705 GLY A 716 1 12 HELIX 10 AB1 THR A 726 TRP A 737 1 12 HELIX 11 AB2 VAL A 740 ARG A 744 5 5 HELIX 12 AB3 THR A 746 LEU A 760 1 15 HELIX 13 AB4 PRO B 474 ASP B 476 5 3 HELIX 14 AB5 THR B 521 GLY B 539 1 19 HELIX 15 AB6 ASN B 568 ALA B 575 1 8 HELIX 16 AB7 SER B 596 LYS B 617 1 22 HELIX 17 AB8 ALA B 625 ARG B 627 5 3 HELIX 18 AB9 LEU B 662 TRP B 666 5 5 HELIX 19 AC1 ALA B 668 ARG B 675 1 8 HELIX 20 AC2 THR B 678 THR B 695 1 18 HELIX 21 AC3 PRO B 705 GLU B 715 1 11 HELIX 22 AC4 THR B 726 CYS B 736 1 11 HELIX 23 AC5 VAL B 740 ARG B 744 5 5 HELIX 24 AC6 THR B 746 LEU B 760 1 15 HELIX 25 AC7 ASP C 468 GLU C 472 5 5 HELIX 26 AC8 PRO C 474 ASP C 476 5 3 HELIX 27 AC9 THR C 521 GLY C 539 1 19 HELIX 28 AD1 ASN C 568 ALA C 575 1 8 HELIX 29 AD2 SER C 596 LYS C 617 1 22 HELIX 30 AD3 ALA C 625 ARG C 627 5 3 HELIX 31 AD4 LEU C 662 TRP C 666 5 5 HELIX 32 AD5 ALA C 668 PHE C 673 1 6 HELIX 33 AD6 HIS C 679 THR C 695 1 17 HELIX 34 AD7 PRO C 705 GLY C 716 1 12 HELIX 35 AD8 THR C 726 TRP C 737 1 12 HELIX 36 AD9 THR C 746 LEU C 760 1 15 SHEET 1 AA1 5 LEU A 478 PRO A 483 0 SHEET 2 AA1 5 GLN A 491 ILE A 498 -1 O GLU A 496 N VAL A 479 SHEET 3 AA1 5 VAL A 508 MET A 515 -1 O VAL A 511 N ALA A 495 SHEET 4 AA1 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 AA1 5 LEU A 547 CYS A 551 -1 N CYS A 551 O TYR A 558 SHEET 1 AA2 2 VAL A 629 VAL A 631 0 SHEET 2 AA2 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 AA3 5 LEU B 478 GLU B 486 0 SHEET 2 AA3 5 GLN B 491 ILE B 498 -1 O GLU B 496 N VAL B 479 SHEET 3 AA3 5 VAL B 508 MET B 515 -1 O MET B 515 N GLN B 491 SHEET 4 AA3 5 TYR B 558 GLU B 562 -1 O VAL B 559 N LYS B 514 SHEET 5 AA3 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 AA4 2 VAL B 629 VAL B 631 0 SHEET 2 AA4 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 SHEET 1 AA5 5 LEU C 478 PRO C 483 0 SHEET 2 AA5 5 GLN C 491 ILE C 498 -1 O GLU C 496 N VAL C 479 SHEET 3 AA5 5 VAL C 508 MET C 515 -1 O VAL C 511 N ALA C 495 SHEET 4 AA5 5 TYR C 558 GLU C 562 -1 O VAL C 559 N LYS C 514 SHEET 5 AA5 5 LEU C 547 CYS C 551 -1 N LEU C 548 O ILE C 560 SHEET 1 AA6 2 VAL C 629 VAL C 631 0 SHEET 2 AA6 2 MET C 637 ILE C 639 -1 O LYS C 638 N LEU C 630 LINK SG CYS A 563 C18 O1Y A 801 1555 1555 1.75 LINK SG CYS B 563 C18 O1Y B 801 1555 1555 1.73 LINK SG CYS C 563 C18 O1Y C 801 1555 1555 1.82 SITE 1 AC1 14 LEU A 484 LEU A 494 ALA A 512 LYS A 514 SITE 2 AC1 14 GLU A 531 MET A 535 GLU A 562 CYS A 563 SITE 3 AC1 14 ALA A 564 GLU A 571 LEU A 630 ALA A 640 SITE 4 AC1 14 ASP A 641 PHE A 642 SITE 1 AC2 4 ARG A 470 TRP A 471 LEU A 548 GLY A 549 SITE 1 AC3 4 ARG B 470 TRP B 471 GLU B 472 LEU B 548 SITE 1 AC4 15 LEU B 484 VAL B 492 LEU B 494 LYS B 510 SITE 2 AC4 15 ALA B 512 LYS B 514 GLU B 531 MET B 535 SITE 3 AC4 15 ILE B 545 VAL B 561 GLU B 562 ALA B 564 SITE 4 AC4 15 SER B 565 ALA B 640 ASP B 641 SITE 1 AC5 16 LEU C 484 VAL C 492 LEU C 494 LYS C 510 SITE 2 AC5 16 ALA C 512 LYS C 514 GLU C 531 MET C 535 SITE 3 AC5 16 ILE C 545 VAL C 561 GLU C 562 ALA C 564 SITE 4 AC5 16 SER C 565 LEU C 630 ALA C 640 ASP C 641 CRYST1 192.500 79.273 96.718 90.00 110.53 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005195 0.000000 0.001946 0.00000 SCALE2 0.000000 0.012615 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011041 0.00000